What can we expect from the serotonergic side of L-DOPA?

Revue neurologique
Philippe De Deurwaerdere, Sylvia Navailles

Abstract

Parkinson's disease has long been associated with neurodegeneration of the dopaminergic neurons located in the substantia nigra. The metabolic precursor L-DOPA, administered exogenously to patients, has proven its superiority over other medications. Yet, its effectiveness is altered after long-term use by diverse motor and non-motor symptoms. Knowledge of its mechanism of action would be necessary to better apprehend the side effects, but do we really know where and how it works? The connexion between L-DOPA and the serotonergic system, after a sort of crusade lasting for more than 40 years, has been acknowledged recently. The purpose of this review, mainly based on preclinical data, is to present the pharmacological and biochemical evidence demonstrating that serotonergic neurons are mainly involved in the enhancement of dopamine transmission induced by L-DOPA. We are addressing thereafter the two main expectations coming from this mechanism that are fundamental and clinical. The fundamental part will focus on the conceptual framework imposed by such a mechanism, questioning notably the notion that the benefit of L-DOPA is associated with a restoration of dopamine levels in the caudate-putamen. The clinical part will discuss s...Continue Reading

References

Jun 1, 1990·British Journal of Pharmacology·N B MercuriG Bernardi
Oct 2, 1970·Science·K Y NgI J Kopin
Mar 14, 1968·The New England Journal of Medicine·G C Cotzias
Oct 1, 1995·Neurology·F DurifY Agid
Feb 1, 1994·Clinical Neuropharmacology·V BonifatiG Meco
Mar 29, 2001·Neuroscience·A LopezJ L Labandeira-Garcia
Jun 8, 2001·Movement Disorders : Official Journal of the Movement Disorder Society·J E Ahlskog, M D Muenter
Aug 27, 2004·Brain : a Journal of Neurology·Raúl de la Fuente-FernándezA Jon Stoessl
Jun 2, 2005·Neurotoxicology·Barbara PicconiPaolo Calabresi
Oct 28, 2005·Journal of Neural Transmission·B ScholtissenA F G Leentjens
Jul 5, 2006·The European Journal of Neuroscience·Christopher BishopPaul D Walker
Feb 9, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Matteo MartiMichele Morari
Apr 25, 2007·Brain : a Journal of Neurology·Manolo CartaAnders Björklund
Oct 19, 2007·Proceedings of the National Academy of Sciences of the United States of America·Yasin TemelTrevor Sharp
May 16, 2008·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Kae NakamuraOkihide Hikosaka
Oct 28, 2008·Brain : a Journal of Neurology·Ana MuñozManolo Carta
Dec 31, 2008·Journal of Neuroscience Research·Christopher BishopPaul D Walker
Dec 2, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Laurence Nègre-PagèsUNKNOWN DoPaMiP Study Group
Feb 4, 2010·Parkinsonism & Related Disorders·M Angela Cenci, K Elisabet Ohlin
Feb 4, 2010·Parkinsonism & Related Disorders·Amandine Berthet, Erwan Bezard
Feb 12, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Bénédicte AmilhonSalah El Mestikawy
May 7, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ethan S Bromberg-MartinKae Nakamura
Jul 6, 2010·Progress in Neurobiology·Orly WeinrebMoussa B H Youdim
Jul 10, 2010·Neuroscience and Biobehavioral Reviews·Karen L Eskow JaunarajsChristopher Bishop
Jul 10, 2010·Proceedings of the National Academy of Sciences of the United States of America·Ayse UlusoyDeniz Kirik

❮ Previous
Next ❯

Citations

Mar 26, 2016·Progress in Neurobiology·Philippe De Deurwaerdère, Giuseppe Di Giovanni
Jul 9, 2016·Progress in Neurobiology·Philippe De DeurwaerdèreMark J Millan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Basal Ganglia

Basal Ganglia are a group of subcortical nuclei in the brain associated with control of voluntary motor movements, procedural and habit learning, emotion, and cognition. Here is the latest research.

Barrel cortex

Here is the latest research on barrel cortex, a region of somatosensory and motor corticies in the brain, which are used by animals that rely on whiskers for world exploration.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here